Sodium Citrate (Haemonetics Manufacturing Inc)


Welcome to the PulseAid listing for the Sodium Citrate drug offered from Haemonetics Manufacturing Inc. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Haemonetics Manufacturing Inc
NON-PROPRIETARY NAME: Anticoagulant Sodium Citrate Solution
SUBSTANCE NAME: SODIUM CITRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1978-06-30
END MARKETING DATE: 0000-00-00


Sodium Citrate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSodium Citrate from Haemonetics Manufacturing Inc
LABELER NAME: Haemonetics Manufacturing Inc
DEA SCHEDULE: CII
ACTIVE STRENGTH: 10(g/250mL)
START MARKETING DATE: 1978-06-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53157-798_1a2ad203-63fe-42ac-88c6-23dd28385005
PRODUCT NDC: 53157-798
APPLICATION NUMBER: NDA760305

Other SODIUM CITRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Haemonetics Manufacturing IncSodium Citrate
Medsep CorporationAnticoagulant Sodium Citrate